Displaying One Session
Collaborative session
Tumour-agnostic precision therapeutics: The concept and key successes in clinical practice (ID 1301)
Session Name
Speakers
- Takayuki Yoshino (Kashiwa, Chiba, Japan)
Duration
15 Minutes
Implementing NGS multiplex testing for actionable biomarkers in solid tumours (ID 1302)
Session Name
Speakers
- Hsiang-Fong Kao (Taipei City, Taiwan)
Duration
15 Minutes
Challenges in the development of tumour-agnostic targeted agents (ID 1303)
Session Name
Speakers
- Kan Yonemori (Chuo-ku, Japan)
Duration
15 Minutes
Tumour-agnostic therapies: Considerations on generation of evidence frameworks (ID 1304)
Session Name
Speakers
- Christoph Benedikt Westphalen (Munich, Germany)
Duration
15 Minutes